These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21922530)

  • 1. Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
    Ritho J; Liu H; Hartzema AG; Lottenberg R
    Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530
    [No Abstract]   [Full Text] [Related]  

  • 2. Examining the effectiveness of hydroxyurea in people with sickle cell disease.
    Lanzkron S; Haywood C; Fagan PJ; Rand CS
    J Health Care Poor Underserved; 2010 Feb; 21(1):277-86. PubMed ID: 20173269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
    Tripathi A; Jerrell JM; Stallworth JR
    Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS
    N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.
    Makis AC; Hatzimichael EC; Kolios G; Bourantas KL
    Haematologica; 2004 Mar; 89(3):360-1. PubMed ID: 15020278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell patients find a brand New World.
    Noonan SS
    N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P; Barretto de Mello A; Figueiredo MS
    Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.
    Nzouakou R; Bachir D; Lavaud A; Habibi A; Lee K; Lionnet F; Hulin A; Jouault H; Préhu C; Roudot-Thoraval F; Girot R; Galactéros F
    Acta Haematol; 2011; 125(3):145-52. PubMed ID: 21196716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea for sickle cell anemia.
    Naina HV; Harris S
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].
    Elira Dokekias A; Okandze Elenga JP; Ndinga J; Sanogo I; Sangare A
    Tunis Med; 2005 Jan; 83(1):32-7. PubMed ID: 15881719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment adherence in patients with sickle cell anemia.
    Drotar D
    J Pediatr; 2010 Mar; 156(3):350-1. PubMed ID: 20056235
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease.
    Mahadeo KM; Oyeku S; Taragin B; Rajpathak SN; Moody K; Santizo R; Driscoll MC
    Am J Hematol; 2011 Sep; 86(9):806-8. PubMed ID: 21850660
    [No Abstract]   [Full Text] [Related]  

  • 15. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.
    Stettler N; McKiernan CM; Melin CQ; Adejoro OO; Walczak NB
    JAMA; 2015 Apr; 313(16):1671-2. PubMed ID: 25919532
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
    Powars DR
    J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxurea and sickle cell disease: Its been a long, long time coming.
    Scott JP
    Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea for sickle cell anemia.
    Bachmeyer C; Aractingi S; Lionnet F
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance.
    Mathias JG; Nolan VG; Klesges LM; Badawy SM; Cooper WO; Hankins JS; Smeltzer MP
    JAMA Netw Open; 2021 Oct; 4(10):e2128971. PubMed ID: 34643722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.